Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer (Q37240839)

19 August 2017

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer (English)

1 reference

19 August 2017

0 references

1 reference

Eitan Amir

1

0 references

George Tomlinson

object named as

George Tomlinson

9

0 references

Ian F. Tannock

11

object named as

Ian F Tannock

1 reference

19 August 2017

8

George Dranitsaris

1 reference

19 August 2017

12

Mark Clemons

1 reference

19 August 2017

4

Orit Freedman

1 reference

19 August 2017

Naomi Miller

2

1 reference

19 August 2017

William Geddie

3

1 reference

19 August 2017

Farrah Kassam

5

1 reference

19 August 2017

Christine Simmons

6

1 reference

19 August 2017

Maria Oldfield

7

1 reference

19 August 2017

Andreas Laupacis

10

1 reference

19 August 2017

language of work or name

English

0 references

publication date

28 November 2011

1 reference

Journal of Clinical Oncology

19 August 2017

1 reference

19 August 2017

30

1 reference

19 August 2017

6

1 reference

19 August 2017

587-592

1 reference

Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Receptor conversion in distant breast cancer metastases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

BSCC Code of Practice--fine needle aspiration cytology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Technical pitfalls potentially affecting diagnoses in immunohistochemistry

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Skeletal complications of malignancy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

The variability of estrogen receptors in metastatic breast cancer

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Should liver metastases of breast cancer be biopsied to improve treatment choice?

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Should a biopsy be recommended to confirm metastatic disease in women with breast cancer?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Variation in receptor status between primary and metastatic breast cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Testing for qualitative interactions between treatment effects and patient subsets.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5015424

Estrogen and progesterone receptor concordance between primary and recurrent breast cancer

3 September 2018

1 reference

12 December 2020

HER2 status in a population-derived breast cancer cohort: discordances during tumor progression

1 reference

12 December 2020

Change of HER-2/neu status in a subset of distant metastases from breast carcinomas

1 reference

12 December 2020

HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2010.33.5232

1 reference

19 August 2017

1 reference

19 August 2017

1 reference